(PDF) A Genetic Variant of P53 Restricts the Mucous

A Genetic Variant of P53 Restricts the Mucous Secretory Phenotype by Regulating SPDEF and BCL-2 Expression

Nature Communications - United Kingdom

doi 10.1038/ncomms6567

Full Text

Abstract

Available in full text

Categories

Molecular Biology

Date

November 27, 2014

Authors

Hitendra S. Chand

Gilbert Montano

Scott H. Randell

Yohannes Mebratu

Yohannes Tesfaigzi

Publisher

Springer Science and Business Media LLC

Related search

Long Term Lithium Treatment Suppresses P53 and Bax Expression but Increases BCL-2 Expression

Journal of Biological Chemistry

Molecular Biology

English

Ki-67, P53, BCL-2 and Bax Expression in Urothelial Carcinomas of Urinary Bladder

Turk Patoloji Dergisi

Forensic Medicine

English

Expression of the BCL-3 Proto-Oncogene Suppresses P53 Activation

Genes and Development

Developmental Biology

English

P53,bcl-2, Nm 23 Expression in Mucinous Ovarian Tumors and Relationship of This Expression With Histopathological Parameters

Turkiye Klinikleri Journal of Medical Sciences

English

Role of Stat3 in Regulating P53 Expression and Function

Molecular and Cellular Biology

Molecular Biology

English

A Deacetylase-Deficient SIRT1 Variant Opposes Full-Length SIRT1 in Regulating Tumor Suppressor P53 and Governs Expression of Cancer-Related Genes

Molecular and Cellular Biology

Molecular Biology

English

Downregulation of BCL-2 Expression in Lymphoma Cells by BCL-2 ARE-targeted Modified, Synthetic Ribozyme

Cancer Gene Therapy

Cancer Research

Molecular Medicine

Molecular Biology

English

DNA Synthesis and BCL-2 Expression During Development of Mucous Cell Metaplasia in Airway Epithelium of Rats Exposed to LPS

American Journal of Physiology - Lung Cellular and Molecular Physiology

Respiratory Medicine

English

Effects of Zerumbone on Proliferation and Apoptosis of Esophageal Cancer Cells and on P53 and BCL-2 Expression Levels

Oncology Letters

Cancer Research

English